Examining the Efficacy of a Single Session Mindfulness Oriented Recovery Enhancement Intervention: One MORE

University of Utah1 site in 1 country40 target enrollmentNovember 18, 2021

ConditionsChronic Pain

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Chronic Pain
Sponsor: University of Utah
Enrollment: 40
Locations: 1
Primary Endpoint: Pain Catastrophizing
Status: Completed
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study will be a single-site, two-arm randomized controlled trial conducted among chronic pain patients. Chronic pain patients will be randomized by a computer-generated randomization schedule with simple random allocation (1:1) to either One MORE or a wait-list control condition (WLC). One MORE will be delivered individually via a HIPAA compliant virtual meeting platform.

Registry

clinicaltrials.gov

Start Date

November 18, 2021

End Date

November 27, 2022

Last Updated

3 years ago

Study Type

Interventional

Study Design

Crossover

Sex

All

Investigators

Sponsor

University of Utah

Responsible Party

Principal Investigator

Adam Hanley

Assistant Professor

University of Utah

Eligibility Criteria

Inclusion Criteria

•men/women ≥18 years of age
•current chronic pain diagnosis
•reporting pain ≥3 on 0-10 scale

Exclusion Criteria

•unstable illness judged by clinician to interfere with study participation

Outcomes

Primary Outcomes

Pain Catastrophizing

Time Frame: Will be completed at baseline, week 2, and 1, 2, and 3 months after baseline.

Change in pain catastrophizing from baseline through 3-month follow-up will be assessed with the Pain Catastrophizing Scale. Scores range from 0 to 52, with higher scores reflecting greater pain catastrophizing.

Secondary Outcomes

Pain Intensity(Will be completed at baseline, week 2, and 1, 2, and 3 months after baseline.)
Pain Interference(Will be completed at baseline, week 2, and 1, 2, and 3 months after baseline.)